4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-058931
President and CSO acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tepper Mark · President and CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-14 | Exercise or conversion : show line 1 in the form | +10,000 | $1.00 | $10,000 | 2,110,400 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-11-14 | Exercise or conversion : show line 2 in the form Option to purchase common stock | −10,000 | $1.00 | 2024-04-11 | 10,000 | 261,600 | D |
Loading xslF345X03/doc4.xml…